Glycolysis addiction compensating for a defective pentose phosphate pathway confers gemcitabine sensitivity in SETD2-deficient pancreatic cancer-Reference-Cited by-全球学者库

Glycolysis addiction compensating for a defective pentose phosphate pathway confers gemcitabine sensitivity in SETD2-deficient pancreatic cancer

Published:2022-07 Issue: Volume:615 Page:9-16
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Shen Xuqing^ORCID,Chen Yueyue,Liu Mingzhu,Shi Juanjuan,Tang Yingying,Yang Xiaotong,Xu Dapeng,Yao Hongfei,Lu Ping,Sun Yongwei,Xue Jing,Niu Ningning^ORCID

Funder

Shanghai Rising-Star Program

Shanghai Municipal Natural Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. Epidemiology of pancreatic cancer: global trends, etiology and risk factors;Rawla;World J. Oncol.,2019

2. Pancreatic adenocarcinoma;Ryan;N. Engl. J. Med.,2014

3. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

4. Targeting cancer metabolism: a therapeutic window opens;Vander Heiden;Nat. Rev. Drug Discov.,2011

5. Metabolic phenotype of bladder cancer;Massari;Cancer Treat Rev.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches;Environmental Research;2024-01

2. Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications;Journal of Pancreatology;2023-10-21

3. The role of metabolic reprogramming in pancreatic cancer chemoresistance;Frontiers in Pharmacology;2023-01-09